Publications by authors named "J P Grosse"

The uniqueness in each person's cancer cells and variation in immune infiltrates means that each tumor represents a unique problem, but therapeutic targets can be found among their shared features. Radiation therapy alters the interaction between the cancer cells and the stroma through release of innate adjuvants. The extranuclear DNA that can result from radiation damage of cells can result in production of the second messenger cyclic guanosine monophosphate-adenosine monophosphate (cGAMP) by cyclic GMP-AMP synthase (cGAS).

View Article and Find Full Text PDF

While cell-free liquid biopsy (cfLB) approaches provide simple and inexpensive disease monitoring, cell-based liquid biopsy (cLB) may enable additional molecular genetic assessment of systemic disease heterogeneity and preclinical model development. We investigated 71 blood samples of 62 patients with various advanced cancer types and subjected enriched circulating tumor cells (CTCs) to organoid culture conditions. CTC-derived tumoroid models were characterized by DNA/RNA sequencing and immunohistochemistry, as well as functional drug testing.

View Article and Find Full Text PDF

Stress-related disorders are commonly associated with abnormalities in hypothalamic-pituitary-adrenal (HPA) axis activity. Preliminary studies with cortisol administration in the aftermath of trauma suggest that this HPA axis hormone can potentially prevent maladaptive behavioral and biological stress responses. However, the efficacy of glucocorticoid administration during the peripuberty period has not been tested yet, although this lifetime is a critical time window in brain development and is highly sensitive to the harmful effects of stress.

View Article and Find Full Text PDF
Article Synopsis
  • * The oligosaccharyltransferase (OST) complex, particularly the STT3A/B enzymes, plays a crucial role in this glycosylation and has emerged as a promising target for broad-spectrum antiviral drugs.
  • * The study highlights the balance between the antiviral potential of STT3A/B inhibitors, like NGI-1, and the need to assess their safety for humans, leading to the discovery of improved compounds that ensure both efficacy and lower toxicity risks.
View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on evaluating the effectiveness of PSMA-targeted radioguided surgery (PSMA-RGS) for treating patients with oligometastatic recurrence of prostate cancer, highlighting new regional treatment options.
  • Between 2018 and 2022, 50 out of 53 patients who underwent PSMA-RGS after initial radical prostatectomy were analyzed, with successful removal of pathologically positive lesions in all cases.
  • Although PSMA-RGS showed promise, only 42% of patients remained free from biochemical recurrence during follow-up, indicating the need for further research to better select candidates for this treatment.
View Article and Find Full Text PDF